Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
Crossref DOI link: https://doi.org/10.1007/s00125-017-4289-0
Published Online: 2017-05-19
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kapitza, Christoph
Dahl, Kirsten
Jacobsen, Jacob B.
Axelsen, Mads B.
Flint, Anne
Funding for this research was provided by:
Novo Nordisk A/S
License valid from 2017-05-19